bradykinin, des-arg(9)- has been researched along with Cytokine Release Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aalikhani, M; Alikhani, M; Javadi, A | 1 |
1 other study(ies) available for bradykinin, des-arg(9)- and Cytokine Release Syndrome
Article | Year |
---|---|
Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Bradykinin; Chemokine CXCL5; COVID-19; Cytokine Release Syndrome; Humans; Neutrophils; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Interleukin-8B; SARS-CoV-2 | 2021 |